Error: Could not add to watchlist. X
+ Watchlist

Nabriva Therapeutics PLC

1501176D:US
Ticker Change
1501176D:US has changed to a new ticker symbol
USD
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (EUR) (TTM)
-
Market Cap (USD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.08%
% Price Change
-0.03%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Nabriva Therapeutics plc operates as a clinical-stage biopharmaceutical company. The Company researches and develops intravenous (IV) and oral formulations of lefamulin for the treatment of community-acquired bacterial pneumonia (CABP). Nabriva Therapeutics serves patients in worldwide.
Address
25-28 North Wall Quay
IFSC
Dublin 1
Ireland
Phone
353-1-649-2000
Show More